Skip to main content
News

Diabetes drug Tzield yields Rockville’s MacroGenics a big check for royalty stake – Washington Business Journal

By March 13, 2023No Comments
Scott Keonig

Scott KeonigThe deal stands to drive hundreds of millions more to the local company over time.

Image: Scott Koenig is president and CEO of Rockville’s MacroGenics. JOANNE S. LAWTON

{iframe}https://www.bizjournals.com/washington/news/2023/03/10/diabetes-drug-tzield-rockville-biotech-sells.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.